skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Determination of /sup 14/CO/sub 2/ in breath and /sup 14/C in stool after oral administration of cholyl-1-(/sup 14/C)glycine: clinical application

Journal Article · · Clin. Chem.; (United States)
OSTI ID:5088302

Twenty patients with intestinal bacterial overgrowth and 20 control subjects were investigated for bile acid deconjugation, by measuring /sup 14/CO/sub 2/ in the breath after cholyl-1-(/sup 14/C)glycine administration. /sup 14/CO/sub 2/ output/24 h was 11.0 +- 5.2% (mean +- SD) in controls and 54.2 +- 14.0% (mean +- SD) in bacterial-overgrowth patients (P < 0.001). /sup 14/CO/sub 2/ excretion rate in 12 h, when normalized to 100% of the dose at the 12th hour, gave an even finer discrimination between the two groups (no false responses). /sup 14/C in stool, analyzed in 20 malabsorption patients and 20 controls by two different techniques, was 6.6 +- 4% and 31.38 +- 20.7% (mean +- SD), respectively. Results by the two different techniques described here correlated well (r = 0.99). Bile acid malabsorption was in reasonable agreement (r = 0.67) with percentage of ''chenoid'' (chenodeoxycholic acid plus ursodeoxycholic acid) in the stool by gas-liquid chromatography; a poorer correlation was observed when ''choloid'' (cholic acid plus its epimers) were plotted vs. /sup 14/C in stool (r = 0.57, n = 15).

OSTI ID:
5088302
Journal Information:
Clin. Chem.; (United States), Vol. 23:11
Country of Publication:
United States
Language:
English